ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 302

$610K Total Retail Price of All Prescriptions

Rank: 10 out of 302

438 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

3% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,932 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 649 477 1 2
SIMVASTATIN 640 532 2 3
LISINOPRIL 562 467 3 1
OMEPRAZOLE 426 307 4 7
LOSARTAN POTASSIUM 421 368 5 24
FUROSEMIDE 402 326 6 4
TRAMADOL HCL 346 274 7 16
NIFEDIPINE ER 326 282 8 52
METFORMIN HCL 304 212 9 13
LEVOTHYROXINE SODIUM 303 255 10 9
HYDROCHLOROTHIAZIDE 289 229 11 12
METOPROLOL TARTRATE 284 218 12 5
WARFARIN SODIUM 242 192 13 8
ALENDRONATE SODIUM 222 207 14 49
RANITIDINE HCL 213 177 15 33
PRAVASTATIN SODIUM 189 173 16 17
POTASSIUM CHLORIDE 185 157 17 55
DIOVAN 180 158 18 60
GABAPENTIN 170 115 19 18
ALLOPURINOL 165 134 20 77
NIFEDICAL XL 164 132 21 167
METOPROLOL SUCCINATE 162 121 22 6
DONEPEZIL HCL 159 157 23 27
ATORVASTATIN CALCIUM 157 139 24 10
ATENOLOL 154 124 25 20
COLCRYS 153 147 26 182
CLONIDINE HCL 145 59 27 59
LOSARTAN-HYDROCHLOROTHIAZIDE 144 123 28 90
CARVEDILOL 142 133 29 19
NEXIUM 141 112 30 47
TRIAMTERENE-HCTZ 138 123 31 122
NAPROXEN 132 103 32 120
OXYCODONE-ACETAMINOPHEN 123 77 S2 33 22
GLIPIZIDE ER 121 100 34 162
HYDRALAZINE HCL 107 80 35 48
CITALOPRAM HBR 99 66 36 30
LANTUS 98 69 37 66
LEVETIRACETAM 97 44 38 44
CLOPIDOGREL 94 79 39 23
MIRTAZAPINE 92 89 40 38
GLIPIZIDE XL 91 90 41 219
LOVASTATIN 84 80 42 63
PLAVIX 82 76 43 46
TAMSULOSIN HCL 81 67 44 41
VENTOLIN HFA 79 60 45 127
CRESTOR 77 58 46 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 60 47 53
PROAIR HFA 66 45 48 81
CIPROFLOXACIN HCL 65 55 49 58
KLOR-CON M20 64 56 50 107
GLIPIZIDE 60 53 51 114
PANTOPRAZOLE SODIUM 59 40 52 25
DILTIAZEM HCL 57 56 53 266
DIOVAN HCT 56 41 54 117
COMBIVENT 55 43 55 139
LACTULOSE 52 41 56 89
BYSTOLIC 51 50 57 141
QUINAPRIL HCL 50 44 58 293
RISPERIDONE 50 44 58 40
SERTRALINE HCL 50 26 58 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.